Cost-effectiveness of romosozumab for severe postmenopausal osteoporosis at very high risk of fracture in Mexico
Preprint in medRxiv (February 2024)
The most recent citing publications are shown below. View all 67 publications that cite this research output on Dimensions.
Preprint in medRxiv (February 2024)
Article in Health Technology Assessment (October 2022)
Article in Archives of Osteoporosis (April 2022)